Organon & Co. (OGN)
9.32
-0.27
(-2.82%)
USD |
NYSE |
Jan 22, 11:24
Organon Free Cash Flow: 598.00M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 13.05B |
| Amgen, Inc. | 11.54B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Rockwell Medical, Inc. | -2.936M |
| United Therapeutics Corp. | 1.116B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 264.00M |
| Cash from Investing (Quarterly) | -115.00M |
| Cash from Financing (Quarterly) | -76.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5716 |
| Free Cash Flow to Equity (Quarterly) | 217.00M |
| Free Cash Flow to Firm (Quarterly) | 235.26M |
| Free Cash Flow Yield | 24.64% |